Provider review
Roboclinic review
AI-first intake, then a real provider — but the low rate needs a 12-month plan
Roboclinic, operated by BrickFi, Inc., is an AI-first telehealth platform per prior directory research not independently reconfirmed on this pass since the live site renders as a client-side shell with no fetchable pricing content. It starts patients with an AI health assistant, then routes them to a board-certified provider for GLP-1 care — compounded semaglutide from $179/mo (injection) or $249/mo (oral tablets), tirzepatide from $299/mo, with the consult, prescription, and delivery bundled into one flat price that doesn't rise with the dose. But that $179/mo rate requires a 12-month plan; month-to-month runs $299/mo for semaglutide and $399/mo for tirzepatide, per the same prior research. Fulfillment routes through OpenLoop Health rather than an individually named compounding pharmacy, no per-state list is published, and refunds are limited to the most recent billing cycle only.
Straight talk: how we earn — some, not all, of these are affiliate links; start a program through one and we may earn a commission at no extra cost to you. Straight about the rest, too: the write-ups say what each provider is actually worth, and a commission does not change a word of them. Full disclosure here.
On this page
The verdict
Roboclinic's AI-assistant-first intake, followed by a board-certified provider, is a distinctive structure among compounded-GLP-1 storefronts, per prior directory research. Its advertised $179/mo semaglutide rate is real but requires a 12-month commitment — month-to-month runs considerably higher, $299/mo for semaglutide and $399/mo for tirzepatide. Fulfillment routes through OpenLoop Health, an established telehealth network, rather than an individually named pharmacy, and refunds only cover the most recent billing cycle, not prior periods. This review rests on prior research rather than a fresh check, since the live site renders as a client-side shell with no static content.
Roboclinic is not ranked on any of our boards. This is a standalone read of what the company publishes about itself — the providers we do rank in this category are on our semaglutide provider ranking. Nothing on this page is a performance claim — see the evidence review for what these compounds do and do not do.
Who it is for, and who it is not
A good fit if
- You're comfortable with an AI-assisted intake before reaching a human provider
- You want a flat price that doesn't rise as your dose increases
- You're willing to commit to a 12-month plan to access the lowest advertised rate
Look elsewhere if
- You want a true month-to-month rate close to the advertised 12-month price
- You want an individually named compounding pharmacy rather than a routed clinical network
- You want a review based on a fresh site read rather than prior research
What it actually costs
What they advertise
Compounded semaglutide from $179/mo, per prior directory research — a 12-month plan rate.
What you actually pay, month to month
Month-to-month runs $299/mo for semaglutide and $399/mo for tirzepatide, per prior research.
The commitment trap
The $179/mo headline requires a 12-month plan; the true month-to-month rate is $299/mo, nearly double.
Checked live on Roboclinic's own site at https://roboclinic.ai/ in August 2026. Prices change without notice — confirm before you buy. Work out what a vial actually gives you with our peptide dose calculator.
What is included
The cheapest headline number in this category is often the one with the least attached to it. Here is what Roboclinic bundles in, and what it does not.
Clinician consult
Board-certified provider visit, following an AI health…
assistant intake, per prior research.
Bloodwork / labs
Not addressed in the sources read.
Follow-ups and dose changes
Not addressed with a specific cadence in the sources read.
Human support
Not addressed with specifics in the sources read.
Injection supplies
Not itemized in the sources read.
Shipping
Delivery bundled into the flat price, per prior research.
Pharmacy, labs and oversight
The pharmacy
Not individually named; fulfillment routed through OpenLoop Health, per prior research.
Oversight
Board-certified provider visit, following an AI health assistant intake, per prior research. Not addressed with a specific cadence in the sources read.
Compounded peptides are not FDA-approved products, and a 503A pharmacy compounds for a named patient while a 503B outsourcing facility manufactures in batches under CGMP. Neither is a quality guarantee on its own — a named facility is simply a fact you can check, and an unnamed “partner pharmacy network” is not. Our guide to verifying a certificate of analysis covers what to ask for.
Where you can get it
Claimed as "all 50 states, restrictions apply," with doctor review gated by region, per prior research.
The honest cons
The part they would rather you skipped
The advertised $179/mo rate requires a 12-month commitment, per prior research — month-to-month runs $299/mo for semaglutide and $399/mo for tirzepatide, nearly double the headline figure, and refunds are limited to the most recent billing cycle only, with none for prior periods.
- Lowest rate requires a 12-month plan; month-to-month nearly doubles the price
- Compounding pharmacy not individually named — fulfillment routed through OpenLoop Health
- No published per-state list; region-gated doctor review
- Refunds limited to the most recent billing cycle only
None of this is unique to Roboclinic — the whole category shares it. What we hold against a provider is the part it hides, and the ways vendors hide things are catalogued in our vendor red-flags guide.
How it compares
The providers we rank on our semaglutide provider ranking, in the order that board ranks them. Roboclinic is not among them: it is reviewed here, not ranked there, and we would rather show you the comparison than pretend the two are the same thing.
- BHBodybuilding Health+One of the deepest peptide catalogues here, and the loosest one
- Enhance MDWrites a flat-price-at-every-dose policy down — and charges near the top for it
- RxSpan MDOral tablet only, at a real $179 monthly rate
- Direct MedsThe plainest price mechanics on either board, from a company with an FDA warning letter
- Synergy RxPublishes a starting number, and nothing about what it commits you to
- Sprout HealthA $150 markdown the site never explains, and a semaglutide price quoted by the quarter
- Strut HealthInjection or troche, but $119 is the auto-refill price only
- MadeMedPrices are published — but there is no monthly option at all
7 more providers rank on our semaglutide provider ranking — see the full ranking. Every provider we review →
Read this before you buy
A provider comparison is half the decision. The other half is whether the compound does anything for you at all — and whether it is allowed where you compete. Growth-hormone secretagogues are banned in tested sport, year-round, and a prescription does not change that.
Facts on this page reflect Roboclinic's own public disclosures when we last checked them, in August 2026. Prices and terms change without notice — confirm on Roboclinic's site before you buy. Provider names and logos on this page identify the company under review; their use does not imply endorsement, sponsorship or affiliation. This page is informational and not medical advice; compounded peptides are not FDA-approved, and growth-hormone secretagogues are banned in tested sport year-round. See our disclosure and editorial policy.